Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma
Clinical trial NCT05717790 · RECRUITING
Trial details
- NCT number
- NCT05717790
- Sponsor
- Fourth Affiliated Hospital of Guangxi Medical University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2024-11-30
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.